Product Information
DORZOLAMIDE-TIMOLOL EYE DROPS is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8927 per ML under NDC 62332055310. Its NADAC has been published 72 times since May 21, 2025.
FDA first approved this application on May 4, 2021. Its Orange Book therapeutic-equivalence code is AT1.
DORZOLAMIDE-TIMOLOL EYE DROPS
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic SolutionStrength
20; 5 mg/mL; mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332055310
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA213099FDA Approved
5/4/2021
TE Code
AT1
On Market Since
5/4/2021
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has been published 72 times since May 21, 2025, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8927 per ML |
|---|---|
| All-time high | $1.1578 (Jun 11, 2025) |
| All-time low | $0.8853 (Jul 22, 2026) |
| 52-week high | $1.0228 |
| 52-week low | $0.8853 |
| Median price | $0.9435 |
| Average price | $0.9797 |
| Largest weekly change | -4.3% (Sep 17, 2025) |
| Weeks tracked | 72 |
| Tracking since | May 21, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DORZOLAMIDE-TIMOLOL EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL EYE DROPS, manufactured by Alembic Pharmaceuticals Inc., is $0.8927 per ML (NDC 62332055310), effective Sep 30, 2026.
How has the price of DORZOLAMIDE-TIMOLOL EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has declined 22.9%. It has been tracked across 72 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL EYE DROPS?
Since May 21, 2025, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has ranged from a low of $0.8853 (Jul 22, 2026) to a high of $1.1578 (Jun 11, 2025), with a median of $0.9435 per ML.
Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE-TIMOLOL EYE DROPS?
DORZOLAMIDE-TIMOLOL EYE DROPS (NDC 62332055310) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.